AI-powered Delirium Prediction, Detection, and Prevention
Company Founded Year
Company Number of Employees
NeuroreHabilitation | NeuroDegenerative | NeuralProstheses
Digital & Health care
Medical use (pharma, nerve damage rehabilitation, neurodiagnostics. inc. early diagnosis)
CogMe aims to reduce cognitive drops in at-risk populations, initially focusing on delirium in an inpatient setting. Using artificial intelligence, CogMe’s comprehensive solution will analyze the cognitive and biological indicators of individual patients to predict, detect, and intervene in order to prevent cognitive drops.